Harmon J, Spengler J, Coleman McCray J, Nichol S, Spiropoulou C, McElroy A. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis. J Virol. 2018;92: pubmed publisher

Ashrafi S, Shapouri R, Shirkhani A, Mahdavi M. Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model. Biomed Pharmacother. 2018;104:45-51 pubmed publisher

Gai W, Zheng X, Wang C, Wang H, Zhao Y, Wang Q, et al. Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice. Virol J. 2017;14:204 pubmed publisher

Zheng D, Chen S, Qu D, Chen J, Wang F, Zhang R, et al. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. Vaccine. 2016;34:6464-6471 pubmed publisher

Yau A, Piehl F, Olsson T, Holmdahl R. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases. Immunology. 2017;150:408-417 pubmed publisher

Matheoud D, Sugiura A, Bellemare Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell. 2016;166:314-327 pubmed publisher

Tadepalli G, Singh A, Balakrishna K, Murali H, Batra H. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model. Mol Immunol. 2016;71:34-41 pubmed publisher

Yazdi M, Varastehmoradi B, Faghfuri E, Mavandadnejad F, Mahdavi M, Shahverdi A. Adjuvant Effect of Biogenic Selenium Nanoparticles Improves the Immune Responses and Survival of Mice Receiving 4T1 Cell Antigens as Vaccine in Breast Cancer Murine Model. J Nanosci Nanotechnol. 2015;15:10165-72 pubmed

Mazor R, Crown D, Addissie S, Jang Y, Kaplan G, Pastan I. Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo. Cell Mol Immunol. 2017;14:432-442 pubmed publisher

Holmström F, Pasetto A, Nähr V, Brass A, Kriegs M, Hildt E, et al. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice. J Immunol. 2013;190:1113-24 pubmed publisher

Pasetto A, Frelin L, Aleman S, Holmström F, Brass A, Ahlen G, et al. TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity. J Immunol. 2012;189:4510-9 pubmed publisher

Johannsen A, Genolet R, Legler D, Luther S, Luescher I. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice. J Immunol. 2010;185:3445-55 pubmed publisher